PlainRecalls
FDA Drug Moderate Class II Terminated

PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10

Reported: August 14, 2019 Initiated: June 19, 2019 #D-1692-2019

Product Description

PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10

Reason for Recall

Lack of Assurance of Sterility

Details

Recalling Firm
RXQ Compounding LLC
Units Affected
N/A
Distribution
Nationwide USA
Location
Athens, OH

Frequently Asked Questions

What product was recalled?
PHENYLEPHRINE HCL 100 MCG/ML IN NACL 0.9% SYR, 10 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0136-10. Recalled by RXQ Compounding LLC. Units affected: N/A.
Why was this product recalled?
Lack of Assurance of Sterility
Which agency issued this recall?
This recall was issued by the FDA Drug on August 14, 2019. Severity: Moderate. Recall number: D-1692-2019.